Results 91 to 100 of about 3,146 (147)

Complement system in cancer: friend or foe of immunotherapy. [PDF]

J Immunother Cancer
Shah HK, Prem S, Wu X, Liszewski MK, Atkinson JP, Singh AK, Kapoor V.   +6 more
europepmc   +1 more source

Primary membranoproliferative glomerulonephritis: natural history, pathogenesis, and treatment. [PDF]

Front Nephrol
Filippone EJ, Farber JL.
europepmc   +1 more source

A new perspective on AMD pathogenesis: a sequential Factor H-centered view of complement dysregulation. [PDF]

Front Immunol
Skerka C, Cochlovius B, Hüllebrand JP, Goel D, Sood P, Pal N, Chakravarti A, Muth DR, Zeitz O, Zipfel PF.   +9 more
europepmc   +1 more source

The Complosome: An Emerging Intracellular Complement Network in Cancer Development and Therapy. [PDF]

Int J Mol Sci
Zadroga Ł, Lewandowski F, Bębnowska D, Majchrzak A, Czyż A, Niedźwiedzka-Rystwej P.   +5 more
europepmc   +1 more source

Serum complement system activation in normal healing and atrophic non-union of human long bone fractures. [PDF]

Front Immunol
El-Sherbiny YM, Ali YM, Jones E, Giannoudis PV, El-Jawhari JJ.   +4 more
europepmc   +1 more source

Complement-mediated HUS revisited: evolving insights into pathophysiology, diagnosis, and treatment. [PDF]

Front Immunol
Alyamany R, Moyer AM, Willrich MAV, Sridharan M.   +3 more
europepmc   +1 more source

Advances in Complement Research: from Pathophysiology to Precision Medicine. [PDF]

Physiology (Bethesda)
Thurman JM.
europepmc   +1 more source

Overexpression of key complement regulators in glioblastoma. [PDF]

PLoS One
Blomberg L, Raba L, Bengzon J, Osther K, Nittby Redebrandt H.   +4 more
europepmc   +1 more source

Complement Inhibition in Geographic Atrophy: Clinical Evidence for Pegcetacoplan and Avacincaptad Pegol. [PDF]

Cureus
Orozco Loaiza G, Alfaro Guerra MJ, Murillo Sotela A, Villalobos Villalobos P.   +3 more
europepmc   +1 more source